4.4 Article

L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: A multicenter, randomized, double-blind, placebo-controlled trial

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Effect of Propionyl-L-carnitine on a Background of Monitored Exercise in Patients With Claudication Secondary to Peripheral Artery Disease

William R. Hiatt et al.

JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION (2011)

Article Peripheral Vascular Disease

Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease

William R. Hiatt et al.

VASCULAR MEDICINE (2010)

Article Sport Sciences

Responses of criterion variables to different supplemental doses of L-carnitine L-tartrate

Barry A. Spiering et al.

JOURNAL OF STRENGTH AND CONDITIONING RESEARCH (2007)

Article Cardiac & Cardiovascular Systems

The novel phosphodiesterase inhibitor NM-702 improves claudication- limited exercise performance in patients with peripheral arterial disease

Eric P. Brass et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Article Surgery

Impaired muscle oxygen use at onset of exercise in peripheral arterial disease

TA Bauer et al.

JOURNAL OF VASCULAR SURGERY (2004)

Article Endocrinology & Metabolism

L-Carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress

JS Volek et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)

Article Medicine, General & Internal

Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication

WR Hiatt et al.

AMERICAN JOURNAL OF MEDICINE (2001)

Article Medicine, General & Internal

A comparison of cilostazol and pentoxifylline for treating intermittent claudication

DL Dawson et al.

AMERICAN JOURNAL OF MEDICINE (2000)